2021, Number 2
<< Back Next >>
Rev Cub de Tec de la Sal 2021; 12 (2)
Herbology from traditional chinese medicine to successfully fight covid-19
Meyer LA, Columbié PM, Rolando PA
Language: Spanish
References: 32
Page: 117-128
PDF size: 465.83 Kb.
ABSTRACT
Introduction: COVID-19 is a new disease that originated in China in November 2019. The disease is produced by a type of coronavirus, identified as SARS-CoV-2.
Objective: to describe the use of Traditional Chinese Medicine herbal medicine in the treatment of COVID-19 in Portia Clinic during 2020.
Methods: a descriptive cross-sectional study was conducted with 50 patients from the state of Portia Clinic, treated for COVID-19 with Traditional Chinese Medicine phytotherapy. Ethical principles and data confidentiality were complied with. Variables were operationalized to meet the stated objective. The variables were summarized with absolute and relative frequency measures, which were represented in tabular form.
Results: 64% of the group studied was male, with a general predominance of the 50-59 years age group. A PCR was performed in 58% and all of them were positive. Fever and general malaise predominated in more than half of the patients studied. The most frequently observed risk factor was overweight. Eighty percent took infusions during symptoms, while 82% recovered in less than one week.
Conclusions: the SARS-CoV endemic in China between 2002 and 2003 gave rise to reports on the efficacy of ancestral TCM. This served as a basis for combating the pandemic caused by SARS-CoV-2 in patients treated with this alternative therapy, achieving favorable results.
REFERENCES
WHO. Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. Who.int. [cited 2021 May 16]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
China releases genetic data on new coronavirus, now deadly [Internet]. Umn.edu. [cited 2021 May 16]. Available from: https://www.cidrap.umn.edu/news-perspective/2020/01/china-releases-genetic-data-new-coronavirus-now-deadly
Cdc.gov. [cited 2021 May 14]. Available from: https://www.cdc.gov/flu/symptoms/flu-vs-covid19.html
COVID-19 and gender monitor [Internet]. Unwomen.org. [cited 2021 May 15]. Available from: https://data.unwomen.org/resources/covid-19-and-gender-monitor
de Paz C, Muller M, Munoz Boudet AM, Gaddis I. Gender dimensions of the COVID-19 pandemic. World Bank, Washington, DC; 2020.
Coronavirus: the science explained-UKRI. Sex, gender and COVID-19 [Internet]. Ukri.org. [cited 2021 May 16]. Available from: https://coronavirusexplained.ukri.org/en/article/cad0007/
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38.
Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health. 2020;8:152.
Fda.gov. [cited 2021 May 15]. Available from: https://www.fda.gov/media/134922/download
Thevaccinereaction.org. [cited 2021 May 15]. Available from: https://thevaccinereaction.org/2020/11/understanding-pcr-tests-for-coronavirus/
970Universal.com. [cited 2021 May 15]. Available from: https://970universal.com/2021/02/10/dr-sciuto-no-hay-forma-de-diferenciar-el-covid-19-de-un-resfrio/
Smith C. French coronavirus variant can’t be detected by PCR tests [Internet]. Bgr.com. BGR; 2021 [cited 2021 May 16]. Available from: https://bgr.com/tech/coronavirus-french-mutation-undetected-pcr-test-5913752/
Cdc.gov. [cited 2021 May 15]. Available from: https://www.cdc.gov/flu/symptoms/coldflu.html
Yang W, Chen X, Li Y, Guo S, Wang Z, Yu X. Advances in pharmacological activities of terpenoids. Nat Prod Commun. 2020;15(3):1934578X2090355.
Choudhry N, Zhao X, Xu D, Zanin M, Chen W, Yang Z, et al. Chinese therapeutic strategy for fighting COVID-19 and potential small-molecule inhibitors against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). J Med Chem. 2020;63(22):13205–27.
Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, et al. Discovery of a novel inhibitor of Coronavirus 3CL protease as a clinical candidate for the potential treatment of COVID-19. bioRxivorg [Internet]. 2020; Available from: http://dx.doi.org/10.1101/2020.09.12.293498
Khalil AA, Rahman U ur, Khan MR, Sahar A, Mehmood T, Khan M. Essential oil eugenol: sources, extraction techniques and nutraceutical perspectives. RSC Adv. 2017;7(52):32669–81.
Huang M-Z, Yang Y-J, Liu X-W, Qin Z, Li J-Y. Aspirin eugenol ester attenuates oxidative injury of vascular endothelial cells by regulating NOS and Nrf2 signaling pathways. Br J Pharmacol. 2019;176(7):906–18.
Ma N, Liu X-W, Yang Y-J, Li J-Y, Mohamed I, Liu G-R, et al. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model. PLoS One. 2015;10(7):e0133125.
da Silva FFM, Monte FJQ, de Lemos TLG, do Nascimento PGG, de Medeiros Costa AK, de Paiva LMM. Eugenol derivatives: synthesis, characterization, and evaluation of antibacterial and antioxidant activities. Chem Cent J [Internet]. 2018;12(1). Available from: http://dx.doi.org/10.1186/s13065-018-0407-4
Kim K, Park K-I. A review of antiplatelet activity of traditional medicinal herbs on integrative medicine studies. Evid Based Complement Alternat Med. 2019;2019:7125162.
Zhang C, Fan L, Fan S, Wang J, Luo T, Tang Y, et al. Cinnamomum cassia Presl: A review of its traditional uses, phytochemistry, pharmacology and toxicology. Molecules. 2019;24(19):3473.
globalnewscommunication. Riconoscimenti dal Mondo sulle ricerche del cardiologo italiano, Giampaolo Palma, su Malattia Coagulativa da Covid-19 [Internet]. Altervista.org. 2020 [cited 2021 May 16]. Available from: http://globalnewscommunication.altervista.org/2020/05/14/riconoscimenti-dal-mondo-sulle-ricerche-del-cardiologo-italiano-giampaolo-palma-su-malattia-coagulativa-da-covid-19/
Aiello V. Le autopsie (che il Ministero non voleva. rivelano la causa di morte dei pazienti con coronavirus [Internet]. Scienze fanpage. 2020 [cited 2021 May 18]. Available from: https://scienze.fanpage.it/le-autopsie-che-il-ministero-non-voleva-rivelano-la-causa-di-morte-dei-pazienti-con-coronavirus/
Singh NA, Kumar P, Jyoti, Kumar N. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19. Phytother Res [Internet]. 2021;(ptr.7019). Available from: http://dx.doi.org/10.1002/ptr.7019
Parham S, Kharazi AZ, Bakhsheshi-Rad HR, Nur H, Ismail AF, Sharif S, et al. Antioxidant, antimicrobial and antiviral properties of herbal materials. Antioxidants (Basel). 2020;9(12):1309.
Goswami D, Kumar M, Ghosh SK, Das A. Natural Product Compounds in Alpinia officinarum and Ginger are Potent SARS-CoV-2 Papain-like Protease Inhibitors [Internet]. ChemRxiv. 2020. Available from: http://dx.doi.org/10.26434/chemrxiv.12071997
Plantsjournal.com. [cited 2021 May 15]. Available from: https://www.plantsjournal.com/archives/2018/vol6issue2/PartC/6-2-42-182.pdf
Tran HTT, Le NPK, Gigl M, Dawid C, Lamy E. Common dandelion (Taraxacum officinale. efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro [Internet]. bioRxiv. 2021. Available from: http://dx.doi.org/10.1101/2021.03.19.435959
Virologyj.com. [cited 2021 May 15]. Available from: http://www.virologyj.com/content/8/1/538
Bitz B. Covid -19, Coronavirus: Herbal Classes based on the Viral Process [Internet]. Weeds & Wildflowers. 2020 [cited 2021 May 15]. Available from: https://medium.com/weeds-wildflowers/covid-19-coronavirus-potential-herbal-protocol-d06a43017ebe
Covid- 19: Coronavirus, potential herbal protocol - Google drive [Internet]. Google.com. [cited 2021 May 15]. Available from: https://docs.google.com/spreadsheets/d/e/2PACX-1vSU2F5ePoL1QFEZJx2N1BMESlZuQM5LoBdgtE2UTPlR2DohPy59RJ5ZySouoyAnpY3wWq1THMNwwxH4/pubhtml